Centocor Partners Neurochem to Gain Access to Amyloidosis Drug
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 56 (Table of Contents)
Published: 5 Feb-2005
DOI: 10.3833/pdr.v2005.i56.725 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Centocor entered into a collaboration and distribution agreement with Neurochem to gain access to Fibrillex™ (1,3-propanedisulfonate), indicated for the treatment of AA amyloidosis...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS